FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

18218011000036100: Karvezide 300/12.5 (hydrochlorothiazide 12.5 mg + irbesartan 300 mg) tablet, 30 tablets, bottle (containered trade product pack)


Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3671351000168112 Karvezide 300/12.5 tablet, 30, bottle en Synonym Active Case sensitive Australian Medicines Terminology module
3671361000168114 Karvezide 300/12.5 (hydrochlorothiazide 12.5 mg + irbesartan 300 mg) tablet, 30 tablets, bottle (containered trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Karvezide 300/12.5 tablet, 30, bottle has TPUU Karvezide 300/12.5 tablet true Inferred relationship Some 1
Karvezide 300/12.5 tablet, 30, bottle Is a Karvezide 300/12.5 tablet, 30 true Inferred relationship Some
Karvezide 300/12.5 tablet, 30, bottle has TP Karvezide 300/12.5 true Inferred relationship Some
Karvezide 300/12.5 tablet, 30, bottle Is a containered trade product pack true Inferred relationship Some
Karvezide 300/12.5 tablet, 30, bottle Is a Karvezide 300/12.5 film-coated tablet, 30 false Inferred relationship Some
Karvezide 300/12.5 tablet, 30, bottle has container type bottle true Inferred relationship Some
Karvezide 300/12.5 tablet, 30, bottle has TPUU Karvezide 300/12.5 film-coated tablet false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)

Containered trade product pack reference set

Back to Start